Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fibrolamellar hepatocellular carcinoma × sapanisertib × 90 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Genital Diseases 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1 Carcinoma, Endometrioid 1

Interventions

Specimen Handling 2 Sorafenib 2 Irinotecan 2 poly ICLC 1 pembrolizumab 1 durvalumab 1 dehydroftorafur 1 atezolizumab 1 Watchful Waiting 1 Vincristine 1 Platinum 1 Oxaliplatin 1 Observation 1 Nivolumab 1 Ipilimumab 1 Gemcitabine 1 Fluorouracil 1 Etoposide 1 Doxorubicin 1 DT2216 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡